Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency

Annals of Pharmacotherapy

Volumn 30, Issue 7-8, 1996, Pages 724-729

  Paap, Christopher M ^a   Simpson, Karon S ^b   Horton, Michael W ^b   Schaefer, Karen L ^c   Lassman, Howard B ^d   Sack, Marshall R ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Center for Clinical Research   (United States)

^c KAISER PERMANENTE   (United States)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; PENTOXIFYLLINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG METABOLISM; FEMALE; GAS LIQUID CHROMATOGRAPHY; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE;

EID: 0030054654     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000702     Document Type: Article

References (8)

1. Ambrus JL, Ambrus CM, Stadler S, Gobert B, Brobat J. The dose response effect of pentoxifylline (Px) on erythrocyte deformability in patients with peripheral arterial disease (PAD) (abstract). Clin Hemorheol 1987;7:868.
2. Ambrus JL, Anain JM, Anain SM, Anain PM, Anain JM Jr, Stadler S. Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal studies. Clin Pharmacol Ther 1990;48:50-6.
3. Streiter RM, Remick DG, Ward PA, Spangler RN, Lynch JP 3d, Larrick J, et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988;155: 1230-6.
4. Beerman B, Inga R, Mansby J, Chamberlain J, McDonald A. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 1985;37:25-8.
5. Smith RV, Waller ES, Doluisio JT, Bauza MT, Puri SK, Ho I. Pharmacokinetics of orally administered pentoxifylline in humans. J Pharm Sci 1986;75:47-52.
6. St Peter W, Opsahl JA, Puri SK, Sabo R, Lassman HB, Halstenson CE. Pharmacokinetics of pentoxifylline and metabolites in subjects with normal and severely impaired renal function and on hemodialysis (abstract). Pharmacotherapy 1993;13:284.
7. Silver MR, Kroboth PD. Pentoxifylline in end-stage renal disease. Drug Intell Clin Pharm 1987;21:976-8.
8. 14C-pentoxifylline in healthy volunteers. Arzneimittelforschung 1989;39:512-7.